Filing Details

Accession Number:
0001669639-16-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-13 16:18:36
Reporting Period:
2016-08-24
Filing Date:
2016-09-13
Accepted Time:
2016-09-13 16:18:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883984 Icu Medical Inc ICUI Surgical & Medical Instruments & Apparatus (3841) 330022692
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669639 Ruth Virginia Sanzone 1408 Caudor Street
Encinitas CA 92024
Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-24 3,049 $0.00 3,049 No 4 M Direct
Common Stock Disposition 2016-08-24 1,146 $0.00 1,903 No 4 F Direct
Common Stock Disposition 2016-09-12 1,903 $121.29 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2016-08-24 3,049 $0.00 3,049 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,098 2018-08-24 No 4 M Direct
Footnotes
  1. These securities are Restricted Stock Units.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.
  3. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.31, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
  5. One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.